Russian Journal of Evidence-Based Gastroenterology, Journal Year: 2024, Volume and Issue: 13(4), P. 40 - 40
Published: Jan. 1, 2024
Language: Английский
Russian Journal of Evidence-Based Gastroenterology, Journal Year: 2024, Volume and Issue: 13(4), P. 40 - 40
Published: Jan. 1, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 14, 2025
Language: Английский
Citations
0Biomolecules, Journal Year: 2023, Volume and Issue: 13(9), P. 1369 - 1369
Published: Sept. 9, 2023
Metabolic dysfunction-associated steatohepatitis (MASH) is one of the major risk factors for chronic liver disease and hepatocellular carcinoma (HCC). The incidence MASH in Western countries continues to rise, driving HCC as third cause cancer-related death worldwide. has become a global health challenge, partly from obesity epidemic promoting metabolic cellular disturbances but also paucity biomarkers its early detection. Over 50% cases are clinically present at late stage, where curative measures no longer beneficial. Currently, there both specific sensitive biological markers early-stage detection HCC. search diagnosis high-risk populations intense. We described potential role surrogates biopsy screening monitoring patients nesting
Language: Английский
Citations
8Endocrine, Journal Year: 2024, Volume and Issue: 86(2), P. 790 - 799
Published: June 24, 2024
Language: Английский
Citations
2Biological Trace Element Research, Journal Year: 2023, Volume and Issue: 202(10), P. 4586 - 4595
Published: Dec. 15, 2023
Language: Английский
Citations
5Life Sciences, Journal Year: 2024, Volume and Issue: 351, P. 122824 - 122824
Published: June 9, 2024
Language: Английский
Citations
1Metabolomics, Journal Year: 2023, Volume and Issue: 19(8)
Published: Aug. 9, 2023
Insulin resistance is associated with multiple complex diseases; however, precise measures of insulin are invasive, expensive, and time-consuming.Develop estimation models for resistance, including sensitivity index (SI) homeostatic model assessment (HOMA-IR) from metabolomics data.Insulin Resistance Atherosclerosis Family Study (IRASFS).Community based.Mexican Americans (MA) African (AA).Estimation i.e. SI HOMA-IR.Least Absolute Shrinkage Selection Operator (LASSO) Elastic Net regression were used to build 1274 metabolites combined clinical data, e.g. age, sex, body mass (BMI). Metabolite data transformed using three approaches, inverse normal transformation, standardization, Box Cox transformation. The analysis was performed in one MA recruitment site (San Luis Valley, Colorado (SLV); N = 450) tested another Antonio, Texas (SA); 473). In addition, the two sites AA sample (Los Angeles, California; 495). Estimated empiric correlated SA (r2 0.77) 0.74) testing datasets. Further, estimated consistently BMI, low-density lipoprotein cholesterol (LDL), triglycerides. We applied similar approaches estimate HOMA-IR results.We have developed a method estimating that has potential application wide range biomedical studies conditions.
Language: Английский
Citations
2The Journal of Clinical Endocrinology & Metabolism, Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 7, 2024
Abstract Context Exercise reduces adiposity, but its influence on bone marrow fat fraction (BMFF) is unknown; nor it known whether a reduction in liver content mediates this reduction. Objectives This work aimed to determine incorporating exercise into lifestyle program the lumbar spine (LS) BMFF and investigate changes mediate any such effect. Methods Ancillary analysis of 2-arm, parallel, nonrandomized clinical trial was conducted at primary care centers Vitoria-Gasteiz, Spain. A total 116 children with overweight/obesity were assigned 22-week family-based (control group [n = 57]) or same plus an intervention (exercise 59]). The compared interventions consisted (two 90-minute sessions/month) supervised (three sessions/week). outcome examined change LS-BMFF between baseline 22 weeks, as estimated by magnetic resonance imaging. effect hepatic also recorded. Results Mean weight loss difference groups 1.4 ± 0.5 kg favor group. Only experienced (effect size [Cohen d] −0.42; CI, −0.86 −0.01). Importantly, 40.9% reductions mediated percentage (indirect effect: β=−0.104; 95% −0.213 −0.019). independent loss. Conclusion addition designed reduce cardiometabolic risk improves health reducing overweight obesity. beneficial appears be fat.
Language: Английский
Citations
0Russian Journal of Evidence-Based Gastroenterology, Journal Year: 2024, Volume and Issue: 13(4), P. 40 - 40
Published: Jan. 1, 2024
Language: Английский
Citations
0